Skip to main content

Posts

Showing posts with the label Biotech

Samsung Galaxy Watch8 Classic Prototype Leaks on eBay – Squircle Design Confirmed!

In a surprising turn of events, a prototype unit of the Samsung Galaxy Watch8 Classic has surfaced on eBay, providing what appears to be the first real-world confirmation of the much-discussed "squircle" design. The term "squircle" – a hybrid of square and circle – has been floating in tech circles for months, and now it seems Samsung is indeed taking a bold step away from its traditional circular watch face design. This development marks a significant moment in the evolution of Samsung's wearables, suggesting not just a cosmetic shift but a broader rethinking of the Galaxy Watch’s usability, ergonomics, and software optimization. In this in-depth breakdown, we’ll explore everything we know so far about the Galaxy Watch8 Classic, the implications of the squircle form factor, the leak’s origin, what the eBay listing reveals, how it compares to past Galaxy Watch models, and what this could mean for the smartwatch market as a whole. 📦 1. The Leak: How the Ga...

Moderna Shares Plunge Amid FDA Leadership Shakeup

 Moderna (NASDAQ:MRNA) shares tumbled 13% pre-market on Monday following news that Dr. Peter Marks, the FDA’s leading vaccine official, was ousted over the weekend. BioNTech (NASDAQ:BNTX) shares also declined by 5.75%. Dr. Marks, recognized for his significant role in Operation Warp Speed and advocacy for vaccine development during the COVID-19 pandemic, resigned after a disagreement with Health and Human Services Secretary Robert F. Kennedy Jr. concerning vaccine misinformation, according to The Wall Street Journal. The departure of Dr. Marks comes at a critical time for the FDA’s Center for Biologics Evaluation and Research (CBER), which he has led since 2016. CBER plays a vital role in ensuring vaccine safety and effectiveness. In his resignation letter, Dr. Marks stated that he could not align with Kennedy’s views, which are often seen as opposing mainstream scientific consensus on vaccines. Truist analyst Joon Lee commented on the situation, noting that companies associated wi...